| Period Ending | Dec 30, 2011 |
|---|
|
Total Revenue
|
2,219,324
| | Cost of Revenue | 1,467,876 | | |
Gross Profit
|
751,448
| |
|
Operating Expenses |
|
Research Development |
-
|
|
Selling General and Administrative | 251,351 |
|
Non Recurring |
-
|
|
Others | 183,985 |
|
|
|
Total Operating Expenses |
-
| | | |
Operating Income or Loss
|
316,112
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 972 |
|
Earnings Before Interest And Taxes | 317,084 |
|
Interest Expense | 190,225 |
|
Income Before Tax | 126,859 |
|
Income Tax Expense |
-
|
|
Minority Interest |
-
|
|
|
|
Net Income From Continuing Ops | 126,859 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
|
Extraordinary Items |
-
|
|
Effect Of Accounting Changes |
-
|
|
Other Items |
-
| | | |
Net Income
|
126,859
| | Preferred Stock And Other Adjustments |
-
| | |
Net Income Applicable To Common Shares
|
126,859
|
|